鉴于一些含有缬氨酸单元的化合物有较好的 生物活性，如缬昔洛韦(Valaciclovir)已成功地取代阿昔洛韦(Acyclovir)作为有效的治疗疱疹(HSV)病毒的一 线药物 [6] ；缬沙坦(Valsartan)也是含有缬氨酸单元的化合物，...
基于36个网页-相关网页
Valaciclovir HCl 盐酸万乃洛韦 ; 盐酸伐昔洛韦 ; 万乃洛韦盐酸盐 ; 万乃洛韦
Valaciclovir Hydrochloride Tablets 盐酸伐昔洛韦片 ; 盐酸万乃洛韦片 ; 伐昔洛韦片 ; 产品
Valaciclovir Hydrochloride 盐酸伐昔洛韦 ; 盐酸万乃洛韦 ; 万乃洛韦 ; 洛韦
Valaciclovir Hydrochloride Capsules 盐酸万乃洛韦胶囊 ; 盐酸伐昔洛韦胶囊
valaciclovir hydrochloride tablet 盐酸伐昔洛韦片
Valaciclovir Hydrochloride Su 伐昔洛韦缓释片
Valaciclovir Hydrochloride Dispersible Tablets 盐酸伐昔洛韦分散片
Valaciclovir Hydrochloride Sustained Release Tablets 盐酸伐昔洛韦缓释片 ; 伐昔洛韦缓释片
Valaciclovir Hydrochloride Sustain 盐酸伐昔洛韦缓释片
Valaciclovir Hydrochloride (VCV)is often formed into traditional tablets and it is dosed 300mg each time and twice per day. It should be used continuously for 10 days to treat herpes zoster and 7 days to treat herpes simplex.
盐酸伐昔洛韦常用剂型为普通片剂,服用方法为每次300mg,每日二次,带状疱疹连续服药10日,单纯疱疹连续服药7日。
参考来源 - 盐酸伐昔洛韦缓释片的研制Early diagnosis and prophylaxis of CMV high-risk group are the key points forpreventing CMV infection after renal transplantation. To D+/R- or D±/R+ recipients using valaciclovir for 90 days is a safe and efficient method for preventing CMV infection.
防止肾移植术后CMV感染关键在于对高危人群的早期诊断和预防,肾移植术后对CMV血清学D+/R-或 D±/R+受者使用万乃洛韦90天是一种预防CMV感染安全、有效的方法。
参考来源 - 盐酸万乃洛韦预防肾移植术后HCMV感染的临床观察·2,447,543篇论文数据，部分数据来源于NoteExpress
应用推荐